Skip to content

Author

M. M. Marinho

We have 2 of 154 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Machine learning-guided QSAR screening of fluconazole analogs and FDA-approved drugs against Candida albicans, with docking, molecular dynamics, and ADMET analysis.

A machine learning-guided quantitative structure-activity relationship (QSAR) workflow was developed to prioritize fluconazole analogs and FDA-approved drugs with predicted antifungal activity against Candida, followed by a structure-based exploration of a cell wall target.

Hamza Age Daudo, E. Marinho, Victor Moreira de Oliveira et al. · 0 citations
Open access 2026

Anticandidal, molecular docking, antioxidant, and cytotoxic effects of the essential oil of Vitex gardneriana Schauer.

It is suggested that V. gardneriana EO has moderate antifungal activity, however, it shows promising potential when combined with conventional antifungal agents and supports future research toward the development of therapeutic formulations.

Amanda L. Barros, F. L. L. de Aguiar, Andréa Maria Neves et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.